Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-15-029972

Chief Financial Officer acquired 3,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Greene Rick Scott Chief Financial Officer 2015-03-27 Grant or award +3,000 $6.86 $20,580 45,000 D
Loading xslF345X03/doc4.xml…